Dry eye management in a Sjögren’s syndrome mouse model by inhibition of p38-MAPK pathway

被引：0
|
作者：
Xiaoyun Ma
Jun Zou
Linping He
Yun Zhang
机构：
[1] Guanghua Integrative Medicine Hospital,Department of Ophthalmology
[2] Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Department of Ophthalmology
[3] Shanghai Academy of Chinese Medical Sciences,Institute of Arthritis Research
来源：
Diagnostic Pathology | / 9卷
关键词：
Sjögren’s syndrome; Dry eye; Interleukin-1β; p38-MAPK pathway;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] The Relationship Between Systemic Immune Inflammatory Level and Dry Eye in Patients with Sjögren's Syndrome
    Uzeli, Ulkem Sen
    Dogan, Ayse Gulsen
    Sahin, Tayfun
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (22)
  • [12] Correlations between clinical parameters of dry eye disease and serologic profiles in Sjögren’s syndrome
    Yunjin Lee
    Hyun Sun Jeon
    Joon Young Hyon
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 2925 - 2932
  • [13] Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death
    Barancik, M
    Htun, P
    Strohm, C
    Kilian, K
    Schaper, W
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 (03) : 474 - 483
  • [14] Ocular Surface Involvements in the Development of Sjögren's Syndrome-Associated Dry Eye in the IL14α Transgenic Mouse
    Zhang, Minjie
    Liang, Yichen
    Wu, Han
    Zong, Rongrong
    Zhang, Xiaobo
    He, Hui
    Reinach, Peter Sol
    Liu, Zuguo
    Shen, Long
    Li, Wei
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2025, 66 (03)
  • [15] Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren’s Syndrome
    Wannita Klinngam
    Srikanth R. Janga
    Changrim Lee
    Yaping Ju
    Frances Yarber
    Mihir Shah
    Hao Guo
    Dandan Wang
    J. Andrew MacKay
    Maria C. Edman
    Sarah F. Hamm-Alvarez
    Scientific Reports, 9
  • [16] Therapeutic Targets in the Management of Dry Eye Disease Associated with Sjögren's Syndrome: An Updated Review of Current Insights and Future Perspectives
    Almulhim, Abdulmohsen
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (06)
  • [17] Development and content validity assessment of the Dry Eye Disease Questionnaire in patients with dry eye disease, meibomian gland dysfunction, and Sjögren’s syndrome dry eye disease
    Brigitte Sloesen
    Alyson Young
    Katie Forde
    Nicola Hodson
    Sarah Bentley
    Oonagh Walsh
    Christel Naujoks
    Paul O’Brien
    Garima Sharma
    Journal of Patient-Reported Outcomes, 7
  • [18] Inhibition of the p38 MAPK pathway ameliorates renal fibrosis in an NPHP2 mouse model
    Sugiyama, Noriyuki
    Kohno, Michiaki
    Yokoyama, Takahiko
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (04) : 1351 - 1358
  • [19] Fluorescence-based reagent and spectrum-based optical reader for lactoferrin detection in tears: differentiating Sjögren's syndrome from non-Sjögren's dry eye syndrome
    Tsai, Chia-Ying
    Hong, Chitsung
    Hsu, Min-Yen
    Lai, Tso-Ting
    Huang, Ching-Wen
    Lu, Cheng-Yo
    Chen, Wei-Li
    Cheng, Chao-Min
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [20] Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjögren's syndrome-related dry eye
    Vitale S.
    Goodman L.A.
    Reed G.F.
    Smith J.A.
    Health and Quality of Life Outcomes, 2 (1)
12345